Seeking Alpha

Shlomo Wiesen

View Shlomo Wiesen's Comments BY TICKER:
  • A Brand New Chapter And New Opportunities In The Wicked Story Of Cel-Sci Corporation? [View article]
    The survival of CVM is relying on Multikine, everyone knows that. With more and more dilution, Cel Sci is clinging to hope. Geert Kersten does not give me much confidence in the business side of things. He has a handsome salary, and gives me pause about buying CVM stock. As an investor, however, I wonder if it really matters if CVM gets delisted. If hits the pink sheets and subsequently drops a bit more, I would consider jumping in at 50 cents, only because CVM is shaping up to be the only penny stock that has a reasonably legitimate drug in phase III testing. Far from a guarantee, but favorable Multikine news would push this stock to anywhere from 200 to 2000 percent higher. And bad news might make it drop 50%. That's why, despite my dislike of Kersten, and maybe a 15-25% chance of success, I'm probably going to buy if it dips into the .50's.
    Oct 11 09:47 AM | 2 Likes Like |Link to Comment
  • Cel-Sci's Successful Safety Review Not Yet Factored Into Valuation [View article]
    The new patent news had a nice ring to it...but still feels like a bandaid on a dropping stock. We need real news.
    Dec 2 02:38 PM | Likes Like |Link to Comment
  • Technical And Fundamental Breakout In Play For CEL-SCI Corporation [View article]
    I agree with most of the info/speculation in this article, but I sold at .55 anyway. These last 2-3 weeks have seen a general uneasiness with the lengths of time and false hopes of many biotechs, possibly due to Euro crash talk which heats up every few weeks and scares people from speculative stocks and back into companies with solid PE's. I'm going to wait until CVM dips into the mid .30's before I scoop up shares again.
    Apr 18 08:41 PM | Likes Like |Link to Comment
More on CVM by Shlomo Wiesen